全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2016 

慢性心力衰竭患者血清血管生成素-2的表达及临床意义
Expression and clinical significance of serum angiopoietin-2 in patients with chronic heart failure

DOI: 10.7652/jdyxb201603007

Keywords: 慢性心力衰竭,血管生成素-2,N-末端脑钠肽前体,左室射血分数,相关性分析
chronic heart failure
,angiopoietin-2,N-terminal pro-B-type natriuretic peptide,left ventricular ejection fraction,correlation analysis

Full-Text   Cite this paper   Add to My Lib

Abstract:

摘要:目的 探讨慢性心力衰竭(CHF)患者血清血管生成素-2(Ang-2)的表达水平及临床意义。方法 选择CHF患者113例,对不同心功能分级(NYHA心功能分级:Ⅰ级32例,Ⅱ级30例,Ⅲ级26例,Ⅳ级25例)的CHF患者血清Ang-2、N-末端利钠肽前体(NT-proBNP)和左室射血分数(LVEF)进行检测,并设对照组20例(同期健康体检者)。结果 NYHA心功能Ⅰ级~Ⅳ级的CHF患者,NT-proBNP和Ang-2的表达水平逐渐升高,各组间差异均具有统计学意义(P<0.05)。相关性分析显示,Ang-2与NT-proBNP呈显著的正相关(r=0.774,P<0.001),Ang-2与LVEF呈显著的负相关(r=-0.725,P<0.001)。结论 Ang-2与心力衰竭严重程度有着明显的相关性,提示其对心力衰竭的诊断及评价预后有一定的临床意义。
ABSTRACT: Objective To investigate the expression of serum angiopoietin-2 (Ang-2) and its clinical significance in patients with chronic heart failure (CHF). Methods The levels of serum Ang-2, N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left ventricular ejection fraction (LVEF) were detected in 113 patients with CHF, who were divided into four groups according to New York Heart Association (NYHA: class Ⅰ, n=32; Ⅱ, n=30; Ⅲ, n=26; Ⅳ, n=25). Another 20 healthy volunteers for physical check-up were chosen as the control group. Results With the change of cardiac function (from Ⅰ to Ⅳ), the levels of plasma Ang-2 and NT-proBNP were increased significantly (P<0.05). The level of serum Ang-2 was positively correlated with NT-proBNP (r=0.774, P<0.001), but negatively correlated with left ventricular ejection fraction (r=-0.725, P<0.001). Conclusion The level of serum Ang-2 has a significant correlation with the severity of heart failure. Ang-2 is expected to be used to predict and evaluate the severity of CHF

References

[1]  CZUCZ J, CERVENAK L, FORHECZ Z, et al. Serum soluble E-selectin and NT-proBNP levels additively predict mortality in diabetic patients with chronic heart failure[J]. Clin Res Cardiol, 2011, 100(7):587-594.
[2]  TAIMEH Z, LOUGHRAN J, BIRKS EJ, et al. Vascular endothelial growth factor in heart failure[J]. Nat Rev Cardiol, 2013, 10(9):519-530.
[3]  CHONG AY, CAINE GJ, LIP GY. Angiopoietin/tie-2 as mediators of angiogenesis: a role in congestive heart failure?[J]. Eur J Clin Invest, 2004, 34(1):9-13.
[4]  PATEL JV, SOSIN M, GUNARATHNE A, et al. Elevated angiogenin levels in chronic heart failure[J]. Ann Med, 2008, 40(6):474-479.
[5]  王超权,田刚. 胱抑素C对慢性心力衰竭患者早期肾脏损害的预测价值[J].西安交通大学学报(医学版), 2011, 32(5):596-599.
[6]  HUNT SA, ABRAHAM WT, CHIN MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation[J]. Circulation, 2009, 119(14):e391-479.
[7]  RICCIUTO DR, DOS SANTOS CC, HAWKES M, et al. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis[J]. Crit Care Med, 2011, 39 (4): 702-710.
[8]  LUKASZ A, BEUTEL G, KUMPERS P, et al. Angiopoietin-2 in adults with congenital heart disease and heart failure[J]. PLoS One, 2013, 8(6):e66861.
[9]  闫稳平,吴学虎,刘晓霞,等. N端脑钠肽与心力衰竭患者严重程度相关性分析[J]. 医药论坛杂志, 2014, 35(6):97-98.
[10]  TOUSOULIS D, PAPAGEORGIOU N, BRIASOULIS A, et al. Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies[J]. Heart Fail Rev, 2012, 17(1):65-79.
[11]  OKA T, AKAZAWA H, NAITO AT, et al. Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure[J]. Circ Res, 2014, 114(3):565-571.
[12]  陈剑,周瑞莉. 高龄冠心病患者血清脑利钠肽、左室射血分数与心功能分级的相关性研究[J]. 中国临床保健杂志, 2012, 15(4):374-375.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133